Olink Bioscience Acquires Rolling Circle Amplification Patents from In Situ RCP | GenomeWeb

This story was originally posted on Nov. 18.

Olink Bioscience of Uppsala, Sweden, this week said that it has acquired three patents related to rolling circle amplification from Danish biotech firm In Situ RCP.

Olink plans to use the IP — which includes patents related to target-primed rolling circle amplification and methods for amplification of circular molecules — to expand its Duolink proximity ligation assay technology for detecting proteins, protein interactions, and protein modifications.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.

Mar
02
Sponsored by
VelaDx

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.